Cancer stem cells are new vistas for predicting the course of breast cancer
Despite progress in treating breast cancer (BC) using a combined approach in view of morphological findings, distant metastases may develop in 30-90 % of patients with primary BC even at its early stages. The cancer stem cell (CSC) theory is one of the versions that could at least partially explain...
Saved in:
Main Authors: | E. A. Maslyukova (Author), S. I. Zabroda (Author), L. I. Korytova (Author), K. M. Pozharissky (Author), G. A. Raskin (Author), O. V. Korytov (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OSTEOPROTEGERIN AS A PREDICTIVE MARKER OF THE COURSE OF BREAST CANCER
by: S. I. Zabroda, et al.
Published: (2015) -
Prognostic value of receptor activator of nuclear factor kappa-B (RANK) marker in patients with breast cancer
by: S. I. Zabroda, et al.
Published: (2015) -
The comparison of the radiation load to the heart and the left anterior descending coronary artery for various modes of radiation treatment of the breast cancer patients
by: A. V. Bondarenko, et al.
Published: (2016) -
The clinical significance of breast cancer stem cells (review of literature)
by: I. B. Schepotin, et al.
Published: (2014) -
Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019)